STAT June 4, 2024
Ed Silverman

Top of the morning to you, and a fine one it is. There is nothing like being greeted with clear blue skies and cool breezes upon waking up today on the Pharmalot campus. Birds are chirping, squirrels are scavenging, official mascots are barking. And we are similarly engaged in early-in-the-day rituals of our own — firing up the trusty coffee kettle for another cup of stimulation. Once again, we are reaching for pistachio creme, a tasty treat. Please feel free to join us. While you consider the invite, here are a few tidbits for you to peruse as you begin the day ahead, which we hope is successful. Best of luck, and do stay in touch. Postcards and telegrams are...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Project Optimus: The evolution of dose optimisation in oncology
Califf: Do right by AI and patients

Share This Article